Fady Ibraham Malik
EVP Research & Development · CYTOKINETICS INC
- 2024
- Oct 6, 2026
- 44
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Fady Ibraham Malik files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert I. Blum - $17.76M in CYTK purchases and sales in the last 12 months
- Andrew Callos - $11.01M in CYTK purchases and sales in the last 12 months
- Sung Lee - $2.51M in CYTK purchases and sales in the last 12 months
- Edward M. Md Kaye - $2.43M in CYTK purchases and sales in the last 12 months
- John T. Henderson - $2.08M in CYTK purchases and sales in the last 12 months
- Wendell Wierenga - $1.88M in CYTK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Fady Ibraham Malik?
Fady Ibraham Malik is a corporate insider, tracked as EVP Research & Development of CYTOKINETICS INC (CYTK). InsiderAlpha holds 44 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Fady Ibraham Malik submitted recently?
5 primary Form 4 filings in the last 90 days, covering 1 company.
Has Fady Ibraham Malik been buying or selling stock?
Recorded transactions: 0 open-market purchases and 46 open-market sales ($8.04M) across all tracked filings.
